Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Muldoon

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The British Journal of Surgery|October 30, 2014
Value of CT-PET after neoadjuvant chemoradiation in the prediction of histological tumour regression, nodal status and survival in oesophageal adenocarcinomaJ A Elliott, N J O'Farrell, S King, et al.
Irish Journal of Medical Science|December 18, 2012
Evolving changes in the management of early oesophageal adenocarcinoma in a tertiary centreN J O'Farrell, J V Reynolds, N Ravi, et al.
Irish Journal of Medical Science|June 1, 2014
Outcomes in gastric and junctional cancer using neoadjuvant and adjuvant chemotherapy (epirubicin, oxaliplatin, and capecitabine) and radical surgeryA M Mongan, R Kalachand, S King, et al.
The British Journal of Surgery|December 31, 2013
Prognostic significance of neuroepithelial transforming gene 1 in adenocarcinoma of the oesophagogastric junctionC Lahiff, C Schilling, M C Cathcart, et al.
British Journal of Cancer|October 7, 2006
(18)FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour responseC M Gillham, J A Lucey, M Keogan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2026
A systematic map of methods for assessing societal benefits of Earth science informationCasey C O'Hara, Mabel Baez-Schon, Rebecca Chaplin-Kramer, et al.
BMC Cancer|June 6, 2017
ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)J V Reynolds, S R Preston, B O'Neill, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The British Journal of Surgery|October 30, 2014
Value of CT-PET after neoadjuvant chemoradiation in the prediction of histological tumour regression, nodal status and survival in oesophageal adenocarcinomaJ A Elliott, N J O'Farrell, S King, et al.
Irish Journal of Medical Science|December 18, 2012
Evolving changes in the management of early oesophageal adenocarcinoma in a tertiary centreN J O'Farrell, J V Reynolds, N Ravi, et al.
Irish Journal of Medical Science|June 1, 2014
Outcomes in gastric and junctional cancer using neoadjuvant and adjuvant chemotherapy (epirubicin, oxaliplatin, and capecitabine) and radical surgeryA M Mongan, R Kalachand, S King, et al.
The British Journal of Surgery|December 31, 2013
Prognostic significance of neuroepithelial transforming gene 1 in adenocarcinoma of the oesophagogastric junctionC Lahiff, C Schilling, M C Cathcart, et al.
British Journal of Cancer|October 7, 2006
(18)FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour responseC M Gillham, J A Lucey, M Keogan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2026
A systematic map of methods for assessing societal benefits of Earth science informationCasey C O'Hara, Mabel Baez-Schon, Rebecca Chaplin-Kramer, et al.
BMC Cancer|June 6, 2017
ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)J V Reynolds, S R Preston, B O'Neill, et al.
Pageof 2